Valuation
- Market cap
- 240,697,000
- Revenue TTM
- $94,570,000
- Net income TTM
- $23,280,000
- PE ratio
- 0.00
- Forward PE
- —
- Profit margin
- 24.62%
- Debt to equity
- 0.00
Trading
- Volume
- 642,000
- Avg volume
- 760,350
- Day's range
- $3.29 – $3.43
- Shares out
- 71,850,000
- Stochastic %K
- 64%
- Beta
- 1.04
- Analysts
- Strong Buy
- Price target
- $11.00
Company profile
SIGA Technologies, Inc., a commercial-stage pharmaceutical company, focuses on the health security market in the United States. The company's lead product is TPOXX, an antiviral drug for the treatment of human smallpox disease caused by variola virus. SIGA Technologies, Inc. was incorporated in 1995 and is headquartered in New York, New York.
- Industry
- Drug Manufacturers - Specialty & Generic
- Sector
- Healthcare
- Phone
- 212 672 9100
- Website
- https://www.siga.com
- Address
- 31 East 62nd Street, New York, United States
Latest news
No headlines yet.
